FDA — authorised 28 January 1991
- Marketing authorisation holder: KING PHARMS
- Status: approved
🇺🇸 Altace in United States
FDA authorised Altace on 28 January 1991
Marketing authorisations
FDA — authorised 28 January 1991
- Application: NDA019901
- Marketing authorisation holder: KING PHARMS LLC
- Local brand name: ALTACE
- Indication: CAPSULE — ORAL
- Status: approved
Altace in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Altace approved in United States?
Yes. FDA authorised it on 28 January 1991; FDA authorised it on 28 January 1991.
Who is the marketing authorisation holder for Altace in United States?
KING PHARMS holds the US marketing authorisation.